180 Life Sciences Corp. ATNF
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
Business overview of 180 Life Sciences Corp. (ATNF)
180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy.
Key Insights
Critical company metrics and information
Latest Closing Price
$1.18Market Cap
$3.75 MillionPrice-Earnings Ratio
0.15Total Outstanding Shares
3.18 Million SharesTotal Employees
4Dividend
No dividendIPO Date
June 27, 2017SIC Description
Pharmaceutical PreparationsPrimary Exchange
NASDAQType
Common StockHeadquarters
3000 el camino real, Palo alto, CA, 94306Homepage
https://www.180lifesciences.com
Historical Stock Splits
If you bought 380 shares of ATNF before December 19, 2022, you'd have 1 share today.
| Execution Date | Split Amount |
|---|---|
| February 28, 2024 | 1-for-19 (Reverse Split) |
| December 19, 2022 | 1-for-20 (Reverse Split) |
Cash Flow Statement
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Financing Activities | $462,994 |
| Net Cash Flow From Investing Activities | $2.47 Million |
| Net Cash Flow From Operating Activities, Continuing | $-2.69 Million |
| Net Cash Flow From Investing Activities, Continuing | $2.23 Million |
| Exchange Gains/Losses | $-240,674 |
| Net Cash Flow From Operating Activities | $-2.69 Million |
Income Statement
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Net Income/Loss Attributable To Noncontrolling Interest | $0 |
| Net Income/Loss Available To Common Stockholders, Basic | $-3.12 Million |
| Operating Income/Loss | $-6.37 Million |
| Net Income/Loss Attributable To Parent | $-3.12 Million |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0 |
| Income/Loss From Continuing Operations Before Tax | $-3.13 Million |
Comprehensive Income
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss | $-3.26 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
| Other Comprehensive Income/Loss | $-3.26 Million |
| Comprehensive Income/Loss Attributable To Parent | $-3.26 Million |
Balance Sheet
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Intangible Assets | $9.24 Million |
| Assets | $10.47 Million |
| Equity | $3.73 Million |
| Other Current Liabilities | $4.29 Million |
| Accounts Payable | $2.09 Million |
| Noncurrent Liabilities | $352,252 |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||
Recent Headlines From The Web
Latest news, press releases, and media coverage about ATNF from trusted financial sources
ⓒ 2025 Financhle. All Rights Reserved.